NOVA

Research Notes

A peptide derived from a fragment of adrenocorticotropic hormone (ACTH), engineered for stability against rapid enzymatic breakdown. Research history traces back to a Russian peptide-design program studying neuroprotection. What the research explores: BDNF and NGF neurotrophin upregulation, dopamine and serotonin pathway modulation, and neuroprotective mechanisms studied in cerebral ischemia models. Semax research is distinguished from anxiolytic compounds by its activating, rather than calming, effect on monoaminergic signaling. What it isn't: a stimulant or registered medicine outside specific jurisdictions. Semax research is most associated with cognitive and neuroprotective study models, and the evidence base includes both animal research and a body of published clinical study in stroke-related contexts.